Multimodality Assessment for Durable Mechanical Circulatory Support Implantation
- PMID: 41300909
- PMCID: PMC12651896
- DOI: 10.3390/diagnostics15222886
Multimodality Assessment for Durable Mechanical Circulatory Support Implantation
Abstract
The prevalence of advanced heart failure (AdHF) is increasing globally, driven by population aging and improved survival rates in chronic heart failure (CHF). Durable Mechanical Circulatory Support (DMCS), particularly Left Ventricular Assist Devices (LVADs), has become a cornerstone in AdHF management. However, its successful implantation requires a comprehensive preoperative evaluation integrating cardiac, hemodynamic, and systemic assessments. Echocardiography and cardiac magnetic resonance (CMR) provide critical data for risk stratification-e.g., LV ejection fraction < 25%, LV end-diastolic diameter < 60 mm, or free wall RV longitudinal strain (fwRVLS) > -14% predict poorer outcomes. Right heart catheterization (RHC) identifies hemodynamic contraindications (PVR > 6 WU, PAPi < 1.5, cardiac index < 2 L/min/m2), while cardiopulmonary exercise testing (CPET) remains pivotal for assessing functional reserve (peak VO2 < 12 mL/kg/min or <50% predicted). Systemic assessment must address renal, hepatic, oncologic, and psychiatric comorbidities that influence surgical risk. Integrating these multimodal data within a multidisciplinary framework-spanning cardiologists, cardiac surgeons, anesthesiologists, and psychologists-optimizes selection and outcomes for DMCS candidates.
Keywords: DMCS; LVAD; advanced heart failure; cardiac magnetic resonance; right heart catheterization; speckle-tracking echocardiography.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., Böhm M., Burri H., Butler J., Čelutkienė J., Chioncel O., et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2021;42:3599–3726. doi: 10.1093/eurheartj/ehab368. Erratum in Eur. Heart J. 2021, 42, 4901. https://doi.org/10.1093/eurheartj/ehab670 . - DOI - PubMed
-
- Crespo-Leiro M.G., Metra M., Lund L.H., Milicic D., Costanzo M.R., Filippatos G., Gustafsson F., Tsui S., Barge-Caballero E., De Jonge N., et al. Advanced heart failure: A position statement of the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2018;20:1505–1535. doi: 10.1002/ejhf.1236. - DOI - PubMed
-
- Mehra M.R., Goldstein D.J., Uriel N., Cleveland J.C., Jr., Yuzefpolskaya M., Salerno C., Walsh M.N., Milano C.A., Patel C.B., Ewald G.A., et al. MOMENTUM 3 Investigators. Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N. Engl. J. Med. 2018;378:1386–1395. doi: 10.1056/NEJMoa1800866. - DOI - PubMed
-
- Gustafsson F., Ben Avraham B., Chioncel O., Hasin T., Grupper A., Shaul A., Nalbantgil S., Hammer Y., Mullens W., Tops L.F., et al. HFA of the ESC position paper on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider Part 3: At the hospital and discharge. ESC Heart Fail. 2021;8:4425–4443. doi: 10.1002/ehf2.13590. Erratum in ESC Heart Fail. 2022, 9, 2061. https://doi.org/10.1002/ehf2.13889 . - DOI - PMC - PubMed
-
- Geavlete O., Antohi L., Ben-Avraham B., Ben Gal T. Durable Therapies in Advanced Chronic Heart Failure. Council for Cardiology Practice; Sophia Antipolis, France: 2023.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
